To our knowledge, this is the first reported case of SARS-CoV-2 infection successfully treated with imatinib. However, elucidating the relevance of any therapeutic intervention from a single case report is always controversial since clinical outcomes may be influenced by some confounding factors such as the concomitant use of other therapies. Nevertheless, taking into account all the above mentioned data, we believe that imatinib should be considered a potential treatment for COVID-19.